Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Tushar Akare
Eligibility
Inclusion criteria
Inclusion criteria: Evidence of fatty liver on ultrasonography of abdomen. Patients who satisfy the European Association for the Study of the Liver Criteria (EASL criteria) for NAFLD will be recruited for the study. EASL criteria for NAFLD is alcohol consumption less than 30 g/day for men and less than 20 g/day for women. Age >18 years and <65 years of any gender.
Exclusion criteria
Exclusion criteria: Subjects having significant alcohol consumption (more than 30 gm/day in case of males and more than 20 gm/day in case of females) Pregnant or lactating women Subjects carrying hepatitis B and/or hepatitis C virus infection Patients with autoimmune hepatic disease Other chronic hepatic diseases i.e. Wilson’s disease, hereditary hemochromatosis, primary billiary cirrhosis etc. Patients on drugs that can lead to fatty liver e.g. methotrexate, amiodarone, anti- retroviral drugs, tamoxifene, barium salts, tetracycline, Estrogen, glucocorticoids, etc. Individuals having DM, metabolic syndrome, dyslipidemia and/or hypothyroidism Individuals having significant alcohol consumption and/or CLD Pregnant or lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting triglyceride Fasting glucose Triglyceride glucose index Liver ElastographyTimepoint: Baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| Severity of diseaseTimepoint: Baseline | — |
Countries
India
Contacts
Public ContactRavinder Garg
Guru gobind singh medical college and hospital faridkot
Outcome results
None listed